Kass Naomi R, Ledbetter Elizabeth, Erickson Timothy A, Yarimi Jonathan M, Zoghbi Anthony, Muscal Eyal, Murray Kristy O, Fisher Kristen S, Sandweiss Alexander J
Division of Pediatric Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas.
Laboratories for Emerging and Tropical Diseases, School of Public Health, Texas A&M University, College Station, Texas.
Pediatr Neurol. 2025 Aug 14;172:71-77. doi: 10.1016/j.pediatrneurol.2025.08.006.
Pediatric N-methyl-d-aspartate receptor (NMDAR) encephalitis (pNMDARE) is characterized by severe neuropsychiatric symptoms and prolonged hospitalization and recovery. Early pNMDARE diagnosis is complicated by neuropsychiatric mimickers requiring strong clinical suspicion to escalate to the required lumbar puncture (LP), delaying diagnosis and treatment. Since autonomic dysfunction is a cardinal feature of pNMDARE, we hypothesized that early vital signs serve as a potential noninvasive biomarker to screen for appropriate escalation of pNMDARE evaluation.
This is a retrospective, case-control analysis of patients with pNMDARE between 2021 and 2023. Patients diagnosed with pNMDARE as determined by clinical presentation and positive cerebrospinal fluid (CSF) antibodies (Abs) were compared with control subjects who were evaluated for pNMDARE, including an LP, but were negative.
Fifty-seven patients were included for analysis: 23 diagnosed with pNMDARE and 34 without. When standardized for age, sex, and height, the pNMDARE group had higher systolic and diastolic BP percentiles (BP%ile) compared with the anti-NMDAR Ab-negative group (systolic BP%: 95.0% ± 2.3% vs 68.8% ± 4.4%, respectively, P < 0.001; diastolic BP%: 88.3% ± 2.8% vs 61.3% ± 4.1%, respectively; P < 0.001). A receiver operator curve indicated that the shortest Euclidian distance for systolic BP%ile was 99%ile (specificity, 85.3%; sensitivity, 65.2% P < 0.0001) and for diastolic BP%ile was 88.5%ile (specificity, 73.5%; sensitivity, 65.2%; P < 0.005).
Although CSF Ab is required for the diagnosis of pNMDARE, screening tools may help hasten clinical suspicion for the need for an LP. We identified elevated BP as a potential differentiating early clinical marker specific to pNMDARE. This fact corroborates our current understanding of dysautonomia in pNMDARE and provides a potential clinical marker suitable for future research and validation.
小儿N-甲基-D-天冬氨酸受体(NMDAR)脑炎(pNMDARE)的特征是严重的神经精神症状以及住院和康复时间延长。早期pNMDARE诊断因存在神经精神症状相似的疾病而变得复杂,这需要高度的临床怀疑才能升级进行必要的腰椎穿刺(LP),从而延误诊断和治疗。由于自主神经功能障碍是pNMDARE的主要特征,我们推测早期生命体征可作为一种潜在的非侵入性生物标志物,用于筛查是否需要进一步评估pNMDARE。
这是一项对2021年至2023年间pNMDARE患者进行的回顾性病例对照分析。将根据临床表现和脑脊液(CSF)抗体(Abs)阳性确诊为pNMDARE的患者与接受pNMDARE评估(包括腰椎穿刺)但结果为阴性的对照受试者进行比较。
纳入57例患者进行分析:23例诊断为pNMDARE,34例未诊断为pNMDARE。在根据年龄、性别和身高进行标准化后,pNMDARE组的收缩压和舒张压百分位数(BP%ile)高于抗NMDAR抗体阴性组(收缩压BP%:分别为95.0%±2.3%和68.8%±4.4%,P<0.001;舒张压BP%:分别为88.3%±2.8%和61.3%±4.1%;P<0.001)。受试者工作特征曲线表明,收缩压BP%ile的最短欧几里得距离为99%ile(特异性为85.3%;敏感性为65.2%,P<0.0001),舒张压BP%ile的最短欧几里得距离为88.5%ile(特异性为73.5%;敏感性为65.2%;P<0.005)。
虽然pNMDARE的诊断需要脑脊液抗体,但筛查工具可能有助于加快对进行腰椎穿刺必要性的临床怀疑。我们发现血压升高是pNMDARE特有的潜在早期鉴别临床标志物。这一事实证实了我们目前对pNMDARE中自主神经功能障碍的理解,并提供了一个适合未来研究和验证的潜在临床标志物。